Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TUDCA in ALS
NCT00877604Phase 2Completed
- Sponsor
- Carlo Besta Neurological Institute
- Start
- Jun 2008
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tauroursodeoxycholic acid in amyotrophic lateral sclerosis (ALS), sponsored by Carlo Besta Neurological Institute. Started Jun 2008; status: completed.
02
Drugs
tauroursodeoxycholic acid
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00877604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00877604.